"A Platform for the Discovery of Novel Microbial Natural Product Chemical Scaffolds and Their Biological Targets"
Heading to Stanford next week for #SDDS2026.
In 7 months, Evoquant has built:
- A 5.2M biosynthetic gene cluster atlas
- An AI platform predicting natural product–target interactions
- A wet-lab pipeline with confirmed bioactivity in 6/6 validation cases (15 in progress)
🧵
1
2
1
0